Cerus (CERS) Share-based Compensation (2010 - 2026)
Cerus (CERS) reported Share-based Compensation of $4.9 million for Q1 2026, down 26.09% on a YoY basis from $6.6 million in Q1 2025, and little changed sequentially from $4.9 million in Q4 2025.
Cerus (CERS) Share-based Compensation (2010 - 2026) Analysis & Trends
Cerus (CERS) has 17 years of Share-based Compensation data on file, last reported at $4.9 million in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation fell 26.09% year-over-year to $4.9 million; the trailing twelve-month figure through Mar 2026 stood at $21.1 million (down 10.62% YoY), and the FY2025 full-year result was $22.9 million, changed 0.0% from the prior year.
- Share-based Compensation was little changed at $4.9 million in Q1 2026, from $4.9 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $7.3 million in Q4 2022 to a low of $4.0 million in Q3 2023.
- A 5-year average of $5.6 million and a median of $5.7 million in 2024 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation slumped 32.42% in 2023 and soared 46.52% in 2024, its largest moves.
- Tracing CERS's Share-based Compensation over 5 years: stood at $7.3 million in 2022, then tumbled by 32.42% to $4.9 million in 2023, then grew by 12.26% to $5.5 million in 2024, then retreated by 10.48% to $4.9 million in 2025, then decreased by 0.47% to $4.9 million in 2026.
- Business Quant data shows CERS's Share-based Compensation at $4.9 million in Q1 2026, $4.9 million in Q4 2025, and $5.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.75 Bn | 176.46 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 68.61 Bn | 67.16 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 48.41 Bn | 44.74 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | 35.80 Mn |
| 7 | GE HealthCare Technologies | 28.12 Bn | 25.83 Bn | 1.98 Bn | 35.00 Mn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.26 Bn | 21.14 Bn | 2.07 Bn | 35.12 Mn |
| 10 | Cerus | 601.84 Mn | 521.42 Mn | 27.89 Mn | 4.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.90 Mn |
| Mar 31, 2026 | 4.90 Mn |
| Dec 31, 2025 | 4.93 Mn |
| Dec 31, 2025 | 4.93 Mn |
| Sep 30, 2025 | 5.62 Mn |
| Sep 30, 2025 | 5.62 Mn |
| Jun 30, 2025 | 5.68 Mn |
| Jun 30, 2025 | 5.68 Mn |
| Mar 31, 2025 | 6.64 Mn |
| Mar 31, 2025 | 6.64 Mn |
| Dec 31, 2024 | 5.50 Mn |
| Dec 31, 2024 | 5.50 Mn |
| Sep 30, 2024 | 5.83 Mn |
| Sep 30, 2024 | 5.83 Mn |
| Jun 30, 2024 | 5.68 Mn |
| Jun 30, 2024 | 5.68 Mn |
| Mar 31, 2024 | 5.86 Mn |
| Mar 31, 2024 | 5.86 Mn |
| Dec 31, 2023 | 4.90 Mn |
| Dec 31, 2023 | 4.90 Mn |